Schedule 13G ownership disclosure
VASCULAR BIOGENICS LTD
Security class unavailable · CUSIP: M96883109
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,623,570
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-009309
- Form type
- SC 13G
- Filer
- Pitango Venture Capital Fund IV, L.P.
- CIK
- CIK 1287224
- Filed
- Feb 17, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership